Valproate attenuates the risk of myocardial infarction in patients with epilepsy: a nationwide cohort study (Q57260389)

Peter Riis Hansen

2

0 references

Gunnar Hilmar Gislason

Gunnar Hilmar Gislason

9

0 references

Christian Torp-Pedersen

8

Christian Torp-Pedersen

0 references

Jonas Bjerring Olesen

1

Jonas Bjerring Olesen

0 references

Peter E Weeke

5

Peter Weeke

0 references

Charlotte Andersson

4

Charlotte Andersson

0 references

Michelle D Schmiegelow

6

Michelle Schmiegelow

0 references

Steen Zabell Abildstrøm

3

Pharmacoepidemiology and Drug Safety

Steen Zabell Abildstrøm

0 references

publication date

9 December 2010

0 references

published in

0 references

volume

20

0 references

issue

2

0 references

page(s)

146-153

0 references

cites work

Valproate attenuates accelerated atherosclerosis in hyperglycemic apoE-deficient mice: evidence in support of a role for endoplasmic reticulum stress and glycogen synthase kinase-3 in lesion development and hepatic steatosis

1 reference

Evidence supporting a role for endoplasmic reticulum stress in the development of atherosclerosis in a hyperglycaemic mouse model.

21 January 2018

1 reference

Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3.

21 January 2018

1 reference

Fasting serum insulin and lipid levels in men with epilepsy

21 January 2018

1 reference

Effects of common anti-epileptic drug monotherapy on serum levels of homocysteine, vitamin B12, folic acid and vitamin B6.

21 January 2018

1 reference

Valproate-induced insulin resistance and obesity in children

21 January 2018

1 reference

Increased oxidative stress in epileptic children treated with valproic acid

21 January 2018

1 reference

Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review

21 January 2018

1 reference

Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial

21 January 2018

1 reference

Increased risk and worse prognosis of myocardial infarction in patients with prior hospitalization for epilepsy--the Stockholm Heart Epidemiology Program

21 January 2018

1 reference

The epidemiology of the comorbidity of epilepsy in the general population

21 January 2018

1 reference

Cause-specific mortality in epilepsy: a cohort study of more than 9,000 patients once hospitalized for epilepsy.

21 January 2018

1 reference

The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people

21 January 2018

1 reference

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

21 January 2018

1 reference

Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery

21 January 2018

1 reference

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein

21 January 2018

1 reference

Epilepsy, Atherosclerosis, Myocardial Infarction, and Carbamazepine

21 January 2018

1 reference

Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy

21 January 2018

1 reference

Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs

21 January 2018

1 reference

Valproate-associated coagulopathies are frequent and variable in children

21 January 2018

1 reference

Capillary microscopy and hemorheology in children during antiepileptic monotherapy with carbamazepine and valproate

21 January 2018

1 reference

High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study

21 January 2018

1 reference

Endoplasmic reticulum stress signaling in disease

21 January 2018

1 reference

Nuclear factor kappa-B and the heart

21 January 2018

1 reference

Central role of glycogen synthase kinase-3beta in endoplasmic reticulum stress-induced caspase-3 activation

21 January 2018

1 reference

Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore

21 January 2018

1 reference

Inhibit GSK-3beta or there's heartbreak dead ahead

21 January 2018

1 reference

Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase--dependent pathway is cardioprotective

21 January 2018

1 reference

Validation of epilepsy diagnoses in the Danish National Hospital Register.

21 January 2018

1 reference

The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry

21 January 2018

1 reference

21 January 2018

1 reference